SMTL ID : 6q4g.1

CDK2 in complex with FragLite37

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 0.98 Å

Oligo State

monomer

Ligands

1 x HJK: 2-[3-(2-azanyl-9~{H}-purin-6-yl)phenyl]ethanoic acid(Non-covalent)

HJK.1: 14 residues within 4Å: Chain A: I.18, G.21, T.22, V.26, A.39, K.41, V.72, F.88, E.89, F.90, L.91, K.137, Q.139, L.142 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.18, A:V.26, A:V.26 Hydrogen bonds: A:T.22, A:K.41, A:E.89, A:L.91, A:L.91 Water bridges: A:Y.23, A:N.140, A:D.153 Salt bridges: A:K.41, A:K.137

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wood, D.J. et al., FragLites-Minimal, Halogenated Fragments Displaying Pharmacophore Doublets. An Efficient Approach to Druggability Assessment and Hit Generation. J.Med.Chem. (2019)

Release Date

2019-03-20

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2